Cost-effectiveness of long acting methylphenidate-OROS in ADHD youths with suboptimal symptom control on immediate-release methylphenidate in The Netherlands

被引：0
|
作者：
Faber, A.
Van Agthoven, M.
L, Kalverdijk
Tobi, H.
De Jong-van den Berg, L.
L, Annemans
Postma, M. J.
机构：
[1] Univ Groningen, Groningen, Netherlands
[2] Janssen Cilag BV, Tilburg, Netherlands
[3] Univ Med Ctr Groningen, Groningen, Netherlands
[4] Hlth Econ & Outcomes Res, Brussels, Belgium
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)63549-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A314 / A315
页数：2
相关论文
共 17 条
  • [1] Long-acting methylphenidate-OROS in youths with attention-deficit hyperactivity disorder suboptimally controlled with immediate-release methylphenidate - A study of cost effectiveness in the Netherlands
    Faber, Adrianne
    van Agthoven, Michel
    Kalverdijk, Luuk J.
    Tobi, Hilde
    de Jong-Van den Berg, Lolkje T. W.
    Annemans, Lieven
    Pastma, Maarten J.
    CNS DRUGS, 2008, 22 (02) : 157 - 170
  • [2] Long-Acting Methylphenidate-OROS in Youths with Attention-Deficit Hyperactivity Disorder Suboptimally Controlled with Immediate-Release MethylphenidateA Study of Cost Effectiveness in The Netherlands
    Adrianne Faber
    Michel van Agthoven
    Luuk J. Kalverdijk
    Hilde Tobi
    Lolkje T. W. de Jong-van den Berg
    Lieven Annemans
    Maarten J. Postma
    CNS Drugs, 2008, 22 : 157 - 170
  • [3] Effectiveness and compatibility of OROS®-methylphenidate for adult with ADHS -: The long-acting methylphenidate in adult ADHD (LAMDA) trial
    Gerwe, Martin
    Philipsen, A.
    Roesler, M.
    Sobanski, E.
    Schaeuble, B.
    Medori, R.
    Trott, G. -E.
    NERVENARZT, 2007, 78 : 208 - 209
  • [4] Transition from immediate-release methylphenidate (ir-mph) to extended-release methylphenidate (OROS®-MPH) improves quality of life of patients with adhd -: a naturalistic study
    Hargarter, L.
    Gerwe, M.
    Czekalla, J.
    Mattejat, F.
    EUROPEAN PSYCHIATRY, 2007, 22 : S253 - S253
  • [5] The effectiveness of OROS® methylphenidate (Concerta®) vs. usual treatment with immediate-release methylphenidate (IR MPH) in children aged 6-12 years with attention deficit hyperactivity disorder (ADHD)
    Steele, M
    Riccardelli, R
    Binder, C
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S442 - S442
  • [6] Probabilistic Markov Model Estimating Cost Effectiveness of Methylphenidate Osmotic-Release Oral System Versus Immediate-Release Methylphenidate in Children and Adolescents: Which Information is Needed?
    Saskia Schawo
    Annemarie van der Kolk
    Clazien Bouwmans
    Lieven Annemans
    Maarten Postma
    Jan Buitelaar
    Michel van Agthoven
    Leona Hakkaart-van Roijen
    PharmacoEconomics, 2015, 33 : 489 - 509
  • [7] Probabilistic Markov Model Estimating Cost Effectiveness of Methylphenidate Osmotic-Release Oral System Versus Immediate-Release Methylphenidate in Children and Adolescents: Which Information is Needed?
    Schawo, Saskia
    van der Kolk, Annemarie
    Bouwmans, Clazien
    Annemans, Lieven
    Postma, Maarten
    Buitelaar, Jan
    van Agthoven, Michel
    Hakkaart-van Roijen, Leona
    PHARMACOECONOMICS, 2015, 33 (05) : 489 - 509
  • [8] Long-Term Efficacy of Methylphenidate Immediate-Release for the Treatment of Childhood ADHD: A Systematic Review and Meta-Analysis
    Moreira Maia, Carlos Renato
    Cortese, Samuele
    Caye, Arthur
    Deakin, Thomas Kuhn
    Polanczyk, Guilherme Vanoni
    Polanczyk, Carisi Anne
    Paim Rohde, Luis Augusto
    JOURNAL OF ATTENTION DISORDERS, 2017, 21 (01) : 3 - 13
  • [9] Exploring the Impact of Once-Daily OROS® Methylphenidate (MPH) on Symptoms and Quality of Life in Children and Adolescents with ADHD Transitioning From Immediate-Release MPH
    Kordon, Andreas
    Stollhoff, Kirsten
    Niederkirchner, Kaete
    Mattejat, Fritz
    Rettig, Klaus
    Schaeuble, Barbara
    POSTGRADUATE MEDICINE, 2011, 123 (05) : 27 - 38
  • [10] Cost-Effectiveness of Extended-Release Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Sub-Optimally Treated with Immediate Release Methylphenidate
    van der Schans, Jurjen
    Kotsopoulos, Nikos
    Hoekstra, Pieter J.
    Hak, Eelko
    Postma, Maarten J.
    PLOS ONE, 2015, 10 (05):
12